menu
    • menu

    Company profile for ABL Bio

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    ABL Bio is one of the world's leading biotech research companies focusing on the development of therapeutic drugs for immuno-oncology & neurodegenerative diseases. Our core values are life-improvement, collaboration, innovation and novel therapy.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    ABL Biokorearepublicofnew Flag
    Country
    Country
    South Korea
    Address
    Address
    2nd floor, 16, Daewangpangyo-ro 712 beon-gil Bundang-gu Parking. 16, Daewangpa...
    Telephone
    Telephone
    (82)31-8018-9800
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.ablbio.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Lilly Bets $2.6B on Korean Biotech's Bispecific Antibodies
    Lilly Bets $2.6B on Korean Biotech's Bispecific Antibodies

    14 Nov 2025

    // PRESS RELEASE

    https://www.ablbio.com/en/company/news_view/895?keyword=

    PRESS RELEASE
    14 Nov 2025
    Share Share
    ABL Bio Taps into Synaffix ADC Tech to Accelerate Development
    ABL Bio Taps into Synaffix ADC Tech to Accelerate Development

    04 Nov 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/abl-bio-taps-into-synaffix-adc-technology-to-accelerate-development-of-bispecific-adc-products-301924608.html

    PR NEWSWIRE
    04 Nov 2025
    Share Share
    ABL Bio, GSK partner on Brain Delivery Platform for Diseases
    ABL Bio, GSK partner on Brain Delivery Platform for Diseases

    08 Apr 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/abl-bio-announces-grabody-b-brain-delivery-platform-license-agreement-with-gsk-to-develop-novel-medicines-for-neurodegenerative-diseases-302421547.html

    PR NEWSWIRE
    08 Apr 2025
    Share Share
    ABL Bio Announces Clinical Collaboration For ABL103 with Keytruda
    ABL Bio Announces Clinical Collaboration For ABL103 with Keytruda

    04 Oct 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/abl-bio-announces-clinical-collaboration-to-evaluate-abl103-in-combination-with-keytruda-pembrolizumab-in-patients-with-solid-tumors-302267530.html

    PR NEWSWIRE
    04 Oct 2024
    Share Share
    Biocytogen Enters Collaboration with ABL Bio to Develop New Bispecific ADC
    Biocytogen Enters Collaboration with ABL Bio to Develop New Bispecific ADC

    25 Mar 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240325027750/en

    BUSINESSWIRE
    25 Mar 2024
    Share Share
    I-Mab and ABL Bio Announce Latest Updates of Antibody TJ-L14B/ABL503
    I-Mab and ABL Bio Announce Latest Updates of Antibody TJ-L14B/ABL503

    10 Oct 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/i-mab-and-abl-bio-announce-latest-updates-of-pd-l1-and-4-1bb-bispecific-antibody-tj-l14babl503-301951981.html

    PR NEWSWIRE
    10 Oct 2023
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search